The 5280 Denver’s Mile High Magazine article discusses the underfunding of companies started solely by women in the United States, with only about 2% of total venture capital investment going to them. In Colorado, the situation is even worse, with female-only founders raising only about 1.2% of the state’s total investment in 2021. Melissa Krebs, an associate professor of chemical and biological engineering at Colorado School of Mines, launched GelSana Therapeutics in 2020, which produces a hydrogel that helps wounds heal faster by reducing inflammation. The company plans to expand its product line to include topical medication that gradually disperses, reducing the need for frequent dressing changes for patients with conditions like diabetic ulcers.
Read about her experience being among very few women in tech and how she is changing the game.
